Cargando…
Myopathy, lactic acidosis and sideroblastic anemia 1 (MLASA1): A 25-year follow-up
Mitochondrial myopathy, lactic acidosis and sideroblastic anemia 1 (MLASA1) is a rare disease caused by biallelic pathogenic variants in the PUS1 gene. There are eleven MLASA1 patients reported worldwide with the majority of the patients originating from the Shiraz region of Iran. The rarity of this...
Autores principales: | Woods, Jeremy, Cederbaum, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796764/ https://www.ncbi.nlm.nih.gov/pubmed/31641589 http://dx.doi.org/10.1016/j.ymgmr.2019.100517 |
Ejemplares similares
-
A Myopathy, Lactic Acidosis, Sideroblastic Anemia (MLASA) Case Due to a Novel PUS1 Mutation
por: Kasapkara, Çiğdem Seher, et al.
Publicado: (2017) -
A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations
por: Shahni, Rojeen, et al.
Publicado: (2013) -
MLASA-1: A Rare Cause of Myopathy with Sideroblastic Anemia
por: Sait, Benazer, et al.
Publicado: (2022) -
The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2
por: Riley, Lisa G., et al.
Publicado: (2018) -
Response to “MLASA1 is a poly-phenic but not a di-phenic condition”
por: Woods, Jeremy, et al.
Publicado: (2019)